SCHEMBL6957968

SCHEMBL6957968

Cc1cc(-c2cc(O)c(C(SC3CCCCC3)c3ccccc3)c(=O)o2)ccc1OCc1cccnc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.36
P2RY12 Q9H244 1/20 0.35
ALDH1A1 P00352 2/20 0.34
LRRK2 Q5S007 1/20 0.34
MAOB P27338 2/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
MRGPRX4 Q96LA9 1/20 0.33
BRD4 O60885 1/20 0.33
GPR132 Q9UNW8 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
CYP19A1 P11511 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
PRKDC P78527 1/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
PPARD Q03181 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6957976 0.80 P2RY12 (0.35) PDE4AP2RY12ALDH1A1BRD4PDE3B
SCHEMBL8535928 0.78 PDCD1 (0.34) PDE4AP2RY12ALDH1A1PDE3BPDE3A
SCHEMBL6964221 0.78 HTR1A (0.41) P2RY12LRRK2MAOBMRGPRX4PDE3B
SCHEMBL6953348 0.76 SMN1; SMN2 (0.41) ALDH1A1CYP19A1PPARDKMT2A
SCHEMBL7370949 0.73 ADAMTS4 (0.40) ALDH1A1GPR132PRKDC
SCHEMBL6964162 0.72 PDE3B (0.46) P2RY12ALDH1A1LRRK2MAOBMRGPRX4
SCHEMBL7376620 0.71 ADAMTS4 (0.42) ALDH1A1GPR132
SCHEMBL6964575 0.70 FFAR4 (0.44) ALDH1A1MAOBMRGPRX4KMT2A
SCHEMBL6963697 0.70 ERN1 (0.35) LRRK2MAOBPDE3BPDE3ACYP19A1
SCHEMBL6959331 0.67 SYK (0.40) MAOBMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP claimed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed